PortalPublikationenCirculating tumor cells: liquid biopsy of cancer.

Circulating tumor cells: liquid biopsy of cancer.

Standard

Circulating tumor cells: liquid biopsy of cancer. / Alix-Panabières, Catherine; Pantel, Klaus.

in: CLIN CHEM, Jahrgang 59, Nr. 1, 1, 2013, S. 110-118.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Alix-Panabières, C & Pantel, K 2013, 'Circulating tumor cells: liquid biopsy of cancer.', CLIN CHEM, Jg. 59, Nr. 1, 1, S. 110-118. <http://www.ncbi.nlm.nih.gov/pubmed/23014601?dopt=Citation>

APA

Alix-Panabières, C., & Pantel, K. (2013). Circulating tumor cells: liquid biopsy of cancer. CLIN CHEM, 59(1), 110-118. [1]. http://www.ncbi.nlm.nih.gov/pubmed/23014601?dopt=Citation

Vancouver

Alix-Panabières C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. CLIN CHEM. 2013;59(1):110-118. 1.

Bibtex

@article{b89e72b22d2e4eeeb1ee66529f7e98d1,
title = "Circulating tumor cells: liquid biopsy of cancer.",
abstract = "The detection and molecular characterization of circulating tumor cells (CTCs) are one of the most active areas of translational cancer research, with >400 clinical studies having included CTCs as a biomarker. The aims of research on CTCs include (a) estimation of the risk for metastatic relapse or metastatic progression (prognostic information), (b) stratification and real-time monitoring of therapies, (c) identification of therapeutic targets and resistance mechanisms, and (d) understanding metastasis development in cancer patients.",
keywords = "Biopsy, Humans, Neoplastic Cells, Circulating/*pathology, Neoplasms/blood/*diagnosis, Biopsy, Humans, Neoplastic Cells, Circulating/*pathology, Neoplasms/blood/*diagnosis",
author = "Catherine Alix-Panabi{\`e}res and Klaus Pantel",
year = "2013",
language = "English",
volume = "59",
pages = "110--118",
journal = "CLIN CHEM",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Circulating tumor cells: liquid biopsy of cancer.

AU - Alix-Panabières, Catherine

AU - Pantel, Klaus

PY - 2013

Y1 - 2013

N2 - The detection and molecular characterization of circulating tumor cells (CTCs) are one of the most active areas of translational cancer research, with >400 clinical studies having included CTCs as a biomarker. The aims of research on CTCs include (a) estimation of the risk for metastatic relapse or metastatic progression (prognostic information), (b) stratification and real-time monitoring of therapies, (c) identification of therapeutic targets and resistance mechanisms, and (d) understanding metastasis development in cancer patients.

AB - The detection and molecular characterization of circulating tumor cells (CTCs) are one of the most active areas of translational cancer research, with >400 clinical studies having included CTCs as a biomarker. The aims of research on CTCs include (a) estimation of the risk for metastatic relapse or metastatic progression (prognostic information), (b) stratification and real-time monitoring of therapies, (c) identification of therapeutic targets and resistance mechanisms, and (d) understanding metastasis development in cancer patients.

KW - Biopsy

KW - Humans

KW - Neoplastic Cells, Circulating/pathology

KW - Neoplasms/blood/diagnosis

KW - Biopsy

KW - Humans

KW - Neoplastic Cells, Circulating/pathology

KW - Neoplasms/blood/diagnosis

M3 - SCORING: Journal article

VL - 59

SP - 110

EP - 118

JO - CLIN CHEM

JF - CLIN CHEM

SN - 0009-9147

IS - 1

M1 - 1

ER -